AKT1 and neoplasm: The release of miR-103a from lung tumor cells can inhibit the activity of PTEN in macrophages, activate the PI3K/AKt pathway to induce the polarization of macrophages to M2 type, and promote tumor metastasis and angiogenesis (8).